# CVRx (CVRX) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/CVRX
## Company Profile
- Ticker: CVRX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech, Cardio-Metabolic
## Stock Data
- Close: 5.94 USD
- Market cap: 144090175.92 USD
- Last updated: 2026-08-06
## Business Overview
### Cardiovascular Neuromodulation
CVRx is a commercial-stage medical-device company focused on neuromodulation therapies for cardiovascular disease. Its technology electrically activates the body's baroreflex to influence autonomic pathways involved in heart-failure progression.
### Barostim Platform
Barostim is the company's implantable therapy for patients with heart failure who remain symptomatic despite guideline-directed medical management. The system is placed by trained physicians and supported through a specialized implanting-center network. CVRx is conducting BENEFIT-HF, a randomized controlled study designed to evaluate Barostim's effect on mortality and heart-failure decompensation in an expanded patient population. The trial complements the company's commercial evidence-generation strategy.
## Why The Stock Is Moving

The latest monitored company update is “CVRx Reports Second Quarter 2026 Financial and Operating Results.” The corresponding closing-price reaction is not yet available.

## Future Catalysts

- CVRx’s catalysts are Barostim adoption, reimbursement, and continued growth in heart-failure and hypertension use cases. The company’s stock tends to move when utilization broadens.

## Recent News
- 2026-08-06 20:05 EST — [CVRx Reports Second Quarter 2026 Financial and Operating Results](https://biopharmsignal.com/news/CVRX/cvrx-reports-second-quarter-2026-financial-and-operating-results-01c03331) — Source: CVRx
- 2026-07-28 12:30 EST — [CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference](https://biopharmsignal.com/news/CVRX/cvrx-to-present-at-canaccord-genuity-s-46th-annual-growth-conference-3209525f) — Source: CVRx
- 2026-07-23 20:30 EST — [CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026](https://biopharmsignal.com/news/CVRX/cvrx-to-report-second-quarter-2026-financial-and-operating-results-and-host-conf-cb424df0) — Source: CVRx
- 2026-06-09 11:30 EST — [CVRx Announces Chief Financial Officer Transition](https://biopharmsignal.com/news/CVRX/cvrx-announces-chief-financial-officer-transition-aaf1cf0d) — Source: CVRx
- 2026-05-27 20:30 EST — [CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference](https://biopharmsignal.com/news/CVRX/cvrx-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference) — Source: CVRx